JOURNAL OF HEPATOLOGY, cilt.76, sa.2, ss.311-318, 2022 (SCI-Expanded, Scopus)
Background & Aims: Several models have recently been developed to predict risk of hepatocellular carcinoma (HCC) in patients with chronic hepatitis B (CHB). Our aims were to develop and validate an artificial intelligence-assisted prediction model of HCC risk.